Report Detail
Global (United States, European Union and China) GABA Receptor Agonist Drug Market Research Report 2019-2025
- RnM3348058 |
- 14 July, 2020 |
- Global |
- 152 Pages |
- QYResearch |
- Pharma & Healthcare
GABA Receptor Agonist Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global GABA Receptor Agonist Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the GABA Receptor Agonist Drug market is segmented into
Bamaluzole
Phenibut
Baclofen
Gaboxadol
Klonopin (clonazepam)
Tiagbine
Segment by Application, the GABA Receptor Agonist Drug market is segmented into
Attention Deficit Hyperactivity Disorder (ADHD)
Psychiatric Disorders and Depression
Alzheimer
Epilepsy and Seizure
Anxiety and Sleep Disorders
Obesity and Alcoholism
Regional and Country-level Analysis
The GABA Receptor Agonist Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the GABA Receptor Agonist Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and GABA Receptor Agonist Drug Market Share Analysis
GABA Receptor Agonist Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in GABA Receptor Agonist Drug business, the date to enter into the GABA Receptor Agonist Drug market, GABA Receptor Agonist Drug product introduction, recent developments, etc.
The major vendors covered:
Advicenne
AstraZeneca
Athena Drug Delivery Solutions
Biocodex
Elan Corporation
Eli Lilly and Company
H.LundBeck, Merck and Co
GlaxoSmithKline
NovaDel Pharma
Novartis
OVATION Pharmaceuticals
Osmotica Pharmaceutical
Pfizer
sanofi-aventis
VIVUS
XenoPort
1 Study Coverage
- 1.1 GABA Receptor Agonist Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key GABA Receptor Agonist Drug Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global GABA Receptor Agonist Drug Market Size Growth Rate by Type
- 1.4.2 Bamaluzole
- 1.4.3 Phenibut
- 1.4.4 Baclofen
- 1.4.5 Gaboxadol
- 1.4.6 Klonopin (clonazepam)
- 1.4.7 Tiagbine
- 1.5 Market by Application
- 1.5.1 Global GABA Receptor Agonist Drug Market Size Growth Rate by Application
- 1.5.2 Attention Deficit Hyperactivity Disorder (ADHD)
- 1.5.3 Psychiatric Disorders and Depression
- 1.5.4 Alzheimer
- 1.5.5 Epilepsy and Seizure
- 1.5.6 Anxiety and Sleep Disorders
- 1.5.7 Obesity and Alcoholism
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global GABA Receptor Agonist Drug Market Size, Estimates and Forecasts
- 2.1.1 Global GABA Receptor Agonist Drug Revenue 2015-2026
- 2.1.2 Global GABA Receptor Agonist Drug Sales 2015-2026
- 2.2 Global GABA Receptor Agonist Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global GABA Receptor Agonist Drug Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global GABA Receptor Agonist Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global GABA Receptor Agonist Drug Competitor Landscape by Players
- 3.1 GABA Receptor Agonist Drug Sales by Manufacturers
- 3.1.1 GABA Receptor Agonist Drug Sales by Manufacturers (2015-2020)
- 3.1.2 GABA Receptor Agonist Drug Sales Market Share by Manufacturers (2015-2020)
- 3.2 GABA Receptor Agonist Drug Revenue by Manufacturers
- 3.2.1 GABA Receptor Agonist Drug Revenue by Manufacturers (2015-2020)
- 3.2.2 GABA Receptor Agonist Drug Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global GABA Receptor Agonist Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by GABA Receptor Agonist Drug Revenue in 2019
- 3.2.5 Global GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 GABA Receptor Agonist Drug Price by Manufacturers
- 3.4 GABA Receptor Agonist Drug Manufacturing Base Distribution, Product Types
- 3.4.1 GABA Receptor Agonist Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers GABA Receptor Agonist Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into GABA Receptor Agonist Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global GABA Receptor Agonist Drug Market Size by Type (2015-2020)
- 4.1.1 Global GABA Receptor Agonist Drug Sales by Type (2015-2020)
- 4.1.2 Global GABA Receptor Agonist Drug Revenue by Type (2015-2020)
- 4.1.3 GABA Receptor Agonist Drug Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global GABA Receptor Agonist Drug Market Size Forecast by Type (2021-2026)
- 4.2.1 Global GABA Receptor Agonist Drug Sales Forecast by Type (2021-2026)
- 4.2.2 Global GABA Receptor Agonist Drug Revenue Forecast by Type (2021-2026)
- 4.2.3 GABA Receptor Agonist Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global GABA Receptor Agonist Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global GABA Receptor Agonist Drug Market Size by Application (2015-2020)
- 5.1.1 Global GABA Receptor Agonist Drug Sales by Application (2015-2020)
- 5.1.2 Global GABA Receptor Agonist Drug Revenue by Application (2015-2020)
- 5.1.3 GABA Receptor Agonist Drug Price by Application (2015-2020)
- 5.2 GABA Receptor Agonist Drug Market Size Forecast by Application (2021-2026)
- 5.2.1 Global GABA Receptor Agonist Drug Sales Forecast by Application (2021-2026)
- 5.2.2 Global GABA Receptor Agonist Drug Revenue Forecast by Application (2021-2026)
- 5.2.3 Global GABA Receptor Agonist Drug Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America GABA Receptor Agonist Drug by Country
- 6.1.1 North America GABA Receptor Agonist Drug Sales by Country
- 6.1.2 North America GABA Receptor Agonist Drug Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America GABA Receptor Agonist Drug Market Facts & Figures by Type
- 6.3 North America GABA Receptor Agonist Drug Market Facts & Figures by Application
7 Europe
- 7.1 Europe GABA Receptor Agonist Drug by Country
- 7.1.1 Europe GABA Receptor Agonist Drug Sales by Country
- 7.1.2 Europe GABA Receptor Agonist Drug Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe GABA Receptor Agonist Drug Market Facts & Figures by Type
- 7.3 Europe GABA Receptor Agonist Drug Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific GABA Receptor Agonist Drug by Region
- 8.1.1 Asia Pacific GABA Receptor Agonist Drug Sales by Region
- 8.1.2 Asia Pacific GABA Receptor Agonist Drug Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific GABA Receptor Agonist Drug Market Facts & Figures by Type
- 8.3 Asia Pacific GABA Receptor Agonist Drug Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America GABA Receptor Agonist Drug by Country
- 9.1.1 Latin America GABA Receptor Agonist Drug Sales by Country
- 9.1.2 Latin America GABA Receptor Agonist Drug Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America GABA Receptor Agonist Drug Market Facts & Figures by Type
- 9.3 Central & South America GABA Receptor Agonist Drug Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa GABA Receptor Agonist Drug by Country
- 10.1.1 Middle East and Africa GABA Receptor Agonist Drug Sales by Country
- 10.1.2 Middle East and Africa GABA Receptor Agonist Drug Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa GABA Receptor Agonist Drug Market Facts & Figures by Type
- 10.3 Middle East and Africa GABA Receptor Agonist Drug Market Facts & Figures by Application
11 Company Profiles
- 11.1 Advicenne
- 11.1.1 Advicenne Corporation Information
- 11.1.2 Advicenne Description and Business Overview
- 11.1.3 Advicenne Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Advicenne GABA Receptor Agonist Drug Products Offered
- 11.1.5 Advicenne Related Developments
- 11.2 AstraZeneca
- 11.2.1 AstraZeneca Corporation Information
- 11.2.2 AstraZeneca Description and Business Overview
- 11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 AstraZeneca GABA Receptor Agonist Drug Products Offered
- 11.2.5 AstraZeneca Related Developments
- 11.3 Athena Drug Delivery Solutions
- 11.3.1 Athena Drug Delivery Solutions Corporation Information
- 11.3.2 Athena Drug Delivery Solutions Description and Business Overview
- 11.3.3 Athena Drug Delivery Solutions Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Products Offered
- 11.3.5 Athena Drug Delivery Solutions Related Developments
- 11.4 Biocodex
- 11.4.1 Biocodex Corporation Information
- 11.4.2 Biocodex Description and Business Overview
- 11.4.3 Biocodex Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Biocodex GABA Receptor Agonist Drug Products Offered
- 11.4.5 Biocodex Related Developments
- 11.5 Elan Corporation
- 11.5.1 Elan Corporation Corporation Information
- 11.5.2 Elan Corporation Description and Business Overview
- 11.5.3 Elan Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Elan Corporation GABA Receptor Agonist Drug Products Offered
- 11.5.5 Elan Corporation Related Developments
- 11.6 Eli Lilly and Company
- 11.6.1 Eli Lilly and Company Corporation Information
- 11.6.2 Eli Lilly and Company Description and Business Overview
- 11.6.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Products Offered
- 11.6.5 Eli Lilly and Company Related Developments
- 11.7 H.LundBeck, Merck and Co
- 11.7.1 H.LundBeck, Merck and Co Corporation Information
- 11.7.2 H.LundBeck, Merck and Co Description and Business Overview
- 11.7.3 H.LundBeck, Merck and Co Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Products Offered
- 11.7.5 H.LundBeck, Merck and Co Related Developments
- 11.8 GlaxoSmithKline
- 11.8.1 GlaxoSmithKline Corporation Information
- 11.8.2 GlaxoSmithKline Description and Business Overview
- 11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Products Offered
- 11.8.5 GlaxoSmithKline Related Developments
- 11.9 NovaDel Pharma
- 11.9.1 NovaDel Pharma Corporation Information
- 11.9.2 NovaDel Pharma Description and Business Overview
- 11.9.3 NovaDel Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 NovaDel Pharma GABA Receptor Agonist Drug Products Offered
- 11.9.5 NovaDel Pharma Related Developments
- 11.10 Novartis
- 11.10.1 Novartis Corporation Information
- 11.10.2 Novartis Description and Business Overview
- 11.10.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Novartis GABA Receptor Agonist Drug Products Offered
- 11.10.5 Novartis Related Developments
- 11.1 Advicenne
- 11.1.1 Advicenne Corporation Information
- 11.1.2 Advicenne Description and Business Overview
- 11.1.3 Advicenne Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Advicenne GABA Receptor Agonist Drug Products Offered
- 11.1.5 Advicenne Related Developments
- 11.12 Osmotica Pharmaceutical
- 11.12.1 Osmotica Pharmaceutical Corporation Information
- 11.12.2 Osmotica Pharmaceutical Description and Business Overview
- 11.12.3 Osmotica Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Osmotica Pharmaceutical Products Offered
- 11.12.5 Osmotica Pharmaceutical Related Developments
- 11.13 Pfizer
- 11.13.1 Pfizer Corporation Information
- 11.13.2 Pfizer Description and Business Overview
- 11.13.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Pfizer Products Offered
- 11.13.5 Pfizer Related Developments
- 11.14 sanofi-aventis
- 11.14.1 sanofi-aventis Corporation Information
- 11.14.2 sanofi-aventis Description and Business Overview
- 11.14.3 sanofi-aventis Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 sanofi-aventis Products Offered
- 11.14.5 sanofi-aventis Related Developments
- 11.15 VIVUS
- 11.15.1 VIVUS Corporation Information
- 11.15.2 VIVUS Description and Business Overview
- 11.15.3 VIVUS Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 VIVUS Products Offered
- 11.15.5 VIVUS Related Developments
- 11.16 XenoPort
- 11.16.1 XenoPort Corporation Information
- 11.16.2 XenoPort Description and Business Overview
- 11.16.3 XenoPort Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 XenoPort Products Offered
- 11.16.5 XenoPort Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 GABA Receptor Agonist Drug Market Estimates and Projections by Region
- 12.1.1 Global GABA Receptor Agonist Drug Sales Forecast by Regions 2021-2026
- 12.1.2 Global GABA Receptor Agonist Drug Revenue Forecast by Regions 2021-2026
- 12.2 North America GABA Receptor Agonist Drug Market Size Forecast (2021-2026)
- 12.2.1 North America: GABA Receptor Agonist Drug Sales Forecast (2021-2026)
- 12.2.2 North America: GABA Receptor Agonist Drug Revenue Forecast (2021-2026)
- 12.2.3 North America: GABA Receptor Agonist Drug Market Size Forecast by Country (2021-2026)
- 12.3 Europe GABA Receptor Agonist Drug Market Size Forecast (2021-2026)
- 12.3.1 Europe: GABA Receptor Agonist Drug Sales Forecast (2021-2026)
- 12.3.2 Europe: GABA Receptor Agonist Drug Revenue Forecast (2021-2026)
- 12.3.3 Europe: GABA Receptor Agonist Drug Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific GABA Receptor Agonist Drug Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: GABA Receptor Agonist Drug Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: GABA Receptor Agonist Drug Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: GABA Receptor Agonist Drug Market Size Forecast by Region (2021-2026)
- 12.5 Latin America GABA Receptor Agonist Drug Market Size Forecast (2021-2026)
- 12.5.1 Latin America: GABA Receptor Agonist Drug Sales Forecast (2021-2026)
- 12.5.2 Latin America: GABA Receptor Agonist Drug Revenue Forecast (2021-2026)
- 12.5.3 Latin America: GABA Receptor Agonist Drug Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa GABA Receptor Agonist Drug Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: GABA Receptor Agonist Drug Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: GABA Receptor Agonist Drug Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: GABA Receptor Agonist Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key GABA Receptor Agonist Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 GABA Receptor Agonist Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on GABA Receptor Agonist Drug. Industry analysis & Market Report on GABA Receptor Agonist Drug is a syndicated market report, published as Global (United States, European Union and China) GABA Receptor Agonist Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of GABA Receptor Agonist Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
